We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02927769
Brief Title: A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment (CheckMate 744)

First Submitted : October 6, 2016
First Submitted that Met QC Criteria : October 6, 2016
First Posted : October 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 30, 2022
Last Update Posted : September 1, 2022